February 28, 2025
BERLIN — Induction therapy with subcutaneous guselkumab demonstrated significant efficacy in patients with moderately to severely active ulcerative colitis (UC), according to results from the phase […]
February 28, 2025
BERLIN — Psychosocial factors, such as anxiety and depression, are associated with an increased risk for both self-reported “clinical” and symptomatic, or “hard,” flare in inflammatory […]
February 28, 2025
TOPLINE: Helicobacter pylori infection was associated with decreased odds of eosinophilic oesophagitis, a meta-analysis showed. METHODOLOGY: Researchers conducted an updated meta-analysis of 19 studies involving over […]
February 27, 2025
BERLIN — Gut microbial biomarkers identified using machine learning can differentiate patients with inflammatory bowel disease (IBD) from healthy control individuals, according to a study presented […]
February 27, 2025
TOPLINE: Two in 5 US adults (approximately 122 million) will have metabolic dysfunction–associated steatotic liver disease (MASLD) by 2050, with a concurrent increase in liver cancer, […]
February 26, 2025
BERLIN — Lusvertikimab, a first-in-class interleukin 7 (IL-7) receptor antagonist, demonstrated clinical and endoscopic efficacy in patients with moderate to severe ulcerative colitis (UC) in the 10-week […]
February 26, 2025
TOPLINE: Uncomplicated diverticulosis was not associated with increased abdominal pain or altered bowel habits. METHODOLOGY: Researchers conducted a population-based cohort study in Sweden to compare the […]
February 26, 2025
Among patients with obesity and compensated cirrhosis, bariatric surgery may significantly lower the risk of developing serious liver disease complications, according to a recent study by […]
February 26, 2025
TOPLINE: The new blood-based assay PAC-MANN-1 (protease activity–based cancer marker using magnetic nanosensor-1) identified pancreatic ductal adenocarcinoma (PDAC) across all stages with high specificity and sensitivity. […]